Dr. Peter A. Barry, PhD was recently awarded a new $1.2 million dollar Pfizer contract to work on the “Immunogenicity of hCMV recombinant gB and pentameric complex proteins in rhCMV-seronegative rhesus macaques at UC Davis”.  For more information on Dr. Barry’s research please visit his research site at http://ccm.ucdavis.edu/faculty/barry/.